Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association - 1 Jun 2016

Freire T O, Boulhosa R S S B, Oliveira L P M, de Jesus R P, Cavalcante L N, Lemaire D C, Toralles M B P, Lyra L G C, Lyra A C

Abstract excerpt

BACKGROUND: Insulin resistance promotes liver disease progression and may be associated with a lower response rate in treated hepatitis C virus (HCV) infected patients. n-3 polyunsaturated fatty acid (PUFA) supplementation may reduce insulin resistance. The present study aimed to evaluate the effect of n-3 PUFA supplementation on insulin resistance in these patients. METHODS: In a randomised, double-blind...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Dietary Supplements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Acids, Omega-3

Share to Fatty Liver

Share to Fish Oils

Share to Hepatitis C, Chronic

Share to Insulin

Share to Insulin Resistance

Source

Identifiers

PMID: 26216648
DOI: 10.1111/jhn.12327

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial.PMID 26216648Read ↗

Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis.Semantic proximity Read ↗

Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.Semantic proximity Read ↗

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.Semantic proximity Read ↗

Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs.Semantic proximity Read ↗

Viral hepatitis infection and insulin resistance: a review of the pathophysiological mechanisms.Semantic proximity Read ↗

Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis.Semantic proximity Read ↗

[Chronic hepatitis C and insulin resistance].Semantic proximity Read ↗

Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus ribavirin.Semantic proximity Read ↗

Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.Semantic proximity Read ↗

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.Semantic proximity Read ↗

Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.